Originally a molecular biologist, Lars Albermann received his PhD from the University of Münster, Germany. For the last 14 years he has been working in several regulatory positions in pharmaceutical industry as well as contributing to a number of industry associations, joining Merck KGaA, Darmstadt, Germany, in 2012. Currently, he is responsible for a team of regulatory experts in Life Science Regulatory Management. The team is working on regulatory topics mainly related to APIs and excipients, supporting a number of manufacturing sites as well as global activities.